Drugs / Capsaicin Palmitate
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07260656 Comparator | Nov 2025 → Nov 2027 expected | diabetic polyneuropathy, neuropathy, painful | Carilion Clinic | Recruiting | No outcome recorded |
| Phase 0 | NCT05649228 Comparator | Dec 2022 → Jan 2024 | — | Carilion Clinic | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Capsaicin Palmitate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07260656 ↗ |
| Known as | Capsadyn | “Topical Palmitated Formulation of Capsaicin (Capsadyn®)” NCT07260656 ↗ |
| Known as | Pal | “Pal is 0.25% palmitated capsaicin.” NCT05649228 ↗ |
| Route | Topical | “A small amount of cream about the size of a U.S. quarter containing 0.25% capsaicin palmitate will be applied to participant's forearm using gloved fingers with visible cream...” NCT05649228 ↗ |